CoChat
Sign Up
Cited by 92Cardiovascular Effects of ExerciseSports injuries and preventionCardiac electrophysiology and arrhythmias

Interassociation Consensus Statement on Cardiovascular Care of College Student-Athletes

Open access
Hainline, Brian, Drezner, Jonathan A., Baggish, Aaron, Harmon, Kimberly G., Emery, Michael S., Myerburg, Robert J., Sanchez, Eduardo, Molossi, Silvana +2 more·2016·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2016.03.527
Open this paper in CoChat — free accountOpen PDF

Abstract

Cardiovascular evaluation and care of college student-athletes is gaining increasing attention from both the public and medical communities. Emerging strategies include screening of the general athlete population, recommendations of permissible levels of participation by athletes with identified cardiovascular conditions, and preparation for responding to unanticipated cardiac events in athletic venues. The primary focus has been sudden cardiac death and the utility of screening with or without advanced cardiac screening. The National Collegiate Athletic Association convened a multidisciplinary task force to address cardiovascular concerns in collegiate student-athletes and to develop consensus for an interassociation statement. This document summarizes the task force deliberations and follow-up discussions, and includes available evidence on cardiovascular risk, pre-participation evaluation, and the recognition of and response to cardiac arrest. Future recommendations for cardiac research initiatives, education, and collaboration are also provided.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2016.03.527

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is limited/conflicting evidence as to the effectiveness of the PPE in identifying conditions that may place largely healthy adolescents and young adults at risk for injury or illness as a result of sport participation.

    “Despite the required nature of this evaluation, there is limited/conflicting evidence as to the effectiveness of the PPE in identifying conditions that may place largely health adolescents and young adults, at risk for injury or illness as a result of sport participation [10].”

    From Pre-exercise screening: role of the primary care physician (2016) · cites this paper as [10]

    The section on evidence evaluating pre-participation screening for cardiovascular risk says there is limited evidence that screening prevents sports-related death in athletes, and that its cardiovascular history questions have not been scientifically validated (page unavailable). This supports concern about PPE effectiveness for cardiovascular risk, but the paper does not establish the broader claim about identifying conditions that put adolescents and young adults at risk for injury or illness generally. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 67

  1. R E F E R E N C E S 1. Herring SA, Kibler WB, Putukian M. Team physician consensus statement: 2013 update. Med Sci Sports Exerc 2013;45:1618-22.
  2. Kligfield P, Gettes LS, Bailey JJ, et al. Recom- mendations for the standardization and interpre- tation of the electrocardiogram; part I: the electrocardiogram and its technology. A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American Col- lege of Cardiology Foundation; and the Heart Rhythm Society. J Am Coll Cardiol 2007;49: 1109-27.
  3. Drezner J. ECG interpretation in athletes. BMJ Learning. Available at: http://learning.bmj.com/ learning/course-intro/.html?courseId¼10042239. Accessed March 24, 2016.
  4. Sarna S, Sahi T, Koskenvuo M, et al. Increased life expectancy of world class male athletes. Med Sci Sports Exerc 1993;25:237-44.
  5. Kujala UM, Sarna S, Kaprio J, et al. Hospital care in later life among former world-class Finnish athletes. JAMA 1996;276:216-20.
  6. Toresdahl BG, Rao AL, Harmon KG, et al. Inci- dence of sudden cardiac arrest in high school student athletes on school campus. Heart Rhythm 2014;11:1190-4.
  7. Maron BJ, Friedman RA, Kligfield P, et al. Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2014;64:1479-514.
  8. Yankelson L, Sadeh B, Gershovitz L, et al. Life- threatening events during endurance sports: is heat stroke more prevalent than arrhythmic death? J Am Coll Cardiol 2014;64:463-9.
  9. Maron BJ, Haas TS, Murphy CJ, et al. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol 2014;63:1636-43.
  10. Maron BJ, Winkel B, Tfelt-Hansen J. Perspec- tives on cardiovascular screening. JAMA 2015;313: 31-2.
  11. Maron BJ, Winkel B, Tfelt-Hansen J. Cardio- vascular screening for young athletes-reply. JAMA 2015;313:1674-5.
  12. Harmon KG, Asif IM, Klossner D, et al. Inci- dence of sudden cardiac death in National Colle- giate Athletic Association athletes. Circulation 2011;123:1594-600.
  13. Harmon KG, Drezner JA. Cardiovascular screening for young athletes. JAMA 2015;313: 1673-4.
  14. Harmon KG, Asif IM, Maleszewski JJ, et al. Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Ath- letic Association athletes: a decade in review. Circulation 2015;132:10-9.
  15. Parsons J, editor. 2014-15 NCAA Sports Med- icine Handbook. 25th edition. Indianapolis, IN: The National Collegiate Athletic Association, 2014.
  16. American Academy of Family Physicians, American Academy of Pediatrics, American College of Sports Medicine, American Medical Society for Sports Medicine. Preparticipation Physical Evalu- ation. Fourth Edition. Elk Grove Village, IL: American Academy of Pediatrics, 2010.
  17. Maron BJ, Douglas PS, Graham TP, et al. Task force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Car- diol 2005;45:1322-6.
  18. Maron BJ, Levine BD, Washington RL, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 2: preparticipation screening for cardiovascular disease in competitive athletes: a scientific statement from the American Heart Association and American College of Cardi- ology. J Am Coll Cardiol 2015;66:2356-61.
  19. Ljungqvist A, Jenoure P, Engebretsen L, et al. The International Olympic Committee (IOC) consensus statement on periodic health evaluation of elite athletes March 2009. Br J Sports Med 2009;43:631-43.
  20. Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26:516-24.
  21. Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health pro- fessionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac De- fects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996;94:850-6.
  22. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: pre- amble, principles, and general considerations: a scientific statement from the American Heart As- sociation and American College of Cardiology. J Am Coll Cardiol 2015;66:2343-9.
  23. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular ab- normalities in competitive athletes: 2007 update: a scientific statement from the American Heart Asso- ciation Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007;115: 1643-55.
  24. Mancia G, Kjeldsen SE, Zappe DH, et al. Car- diovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial. Eur Heart J 2016;37:955-64.
  25. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American Col- lege of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S76-99.
  26. Estes NA III, Kovacs RJ, Baggish AL, et al. Eligi- bility and disqualification recommendations for competitive athletes with cardiovascular abnormal- ities: task force 11: drugs and performance-enhancing substances: a scientific statement from the American Heart Association and American College of Cardiol- ogy. J Am Coll Cardiol 2015;66:2429-33.
  27. Maron BJ, Harris KM, Thompson PD, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular ab- normalities: task force 14: sickle cell trait: a sci- entific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015;66:2444-6.
  28. Dunn TP, Pickham D, Aggarwal S, et al. Limi- tations of current AHA guidelines and proposal of new guidelines for the preparticipation examina- tion of athletes. Clin J Sport Med 2015;25:472-7.
  29. Drezner JA, Prutkin JM, Harmon KG, et al. Cardiovascular screening in college athletes. J Am Coll Cardiol 2015;65:2353-5.
  30. Fudge J, Harmon KG, Owens DS, et al. Car- diovascular screening in adolescents and young adults: a prospective study comparing the Pre- participation Physical Evaluation Monograph 4th Edition and ECG. Br J Sports Med 2014;48:1172-8.
  31. Dvorak J, Grimm K, Schmied C, et al. Devel- opment and implementation of a standardized precompetition medical assessment of interna- tional elite football players-2006 FIFA World Cup Germany. Clin J Sport Med 2009;19:316-21.
  32. Harmon KG, Zigman M, Drezner JA. The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac dis- orders in athletes: a systematic review/meta- analysis. J Electrocardiol 2015;48:329-38.
  33. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010;31: 806-14.
  34. Campbell RM, Berger S, Drezner J. Sudden cardiac arrest in children and young athletes: the importance of a detailed personal and family his- tory in the pre-participation evaluation. Br J Sports Med 2009;43:336-41.
  35. Drezner JA, Ackerman MJ, Cannon BC, et al. Abnormal electrocardiographic findings in ath- letes: recognising changes suggestive of primary electrical disease. Br J Sports Med 2013;47: 153-67.
  36. Basso C, Maron BJ, Corrado D, et al. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000;35:1493-501.
  37. Berte B, Duytschaever M, Elices J, et al. Vari- ability in interpretation of the electrocardiogram in young athletes: an unrecognized obstacle for electrocardiogram-based screening protocols. Europace 2015;17:1435-40.
  38. Sharma S, Dhutia H. Variation of electrocar- diogram interpretation: yet another contributor to the Achilles heel of pre-participation electrocar- diographic programmes in athletes. Europace 2015;17:1323-4.
  39. Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic interpretation in athletes: the 'Seattle Criteria.' Br J Sports Med 2013;47: 122-4.
  40. Brosnan M, La Gerche A, Kalman J, et al. The Seattle Criteria increase the specificity of pre- participation ECG screening among elite athletes. Br J Sports Med 2014;48:1144-50.
  41. Baggish AL, Hutter AM Jr., Wang F, et al. Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Ann Intern Med 2010;152:269-75.
  42. Wasfy MM, DeLuca J, Wang F, et al. ECG findings in competitive rowers: normative data and the prevalence of abnormalities using contemporary screening recommendations. Br J Sports Med 2015;49:200-6.
  43. Graham R, McCoy MA, Schultz AM, editors. Committee on the Treatment of Cardiac Arrest: Current Status and Future Directions; Board on Health Sciences Policy; Institute of Medicine. Strategies to Improve Cardiac Arrest Survival: A Time to Act. Washington, DC: The National Academies Press, 2015.
  44. Myerburg RJ, Ullmann SG. Alternative research funding to improve clinical outcomes: model of prediction and prevention of sudden cardiac death. Circ Arrhythm Electrophysiol 2015;8: 492-8.
  45. Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular ab- normalities: task force 3: hypertrophic cardiomy- opathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015;66:2362-71.
  46. Van Hare GF, Ackerman MJ, Evangelista JA, et al. Eligibility and disqualification recommen- dations for competitive athletes with cardio- vascular abnormalities: task force 4: congenital heart disease: a scientific statement from the American Heart Association and American Col- lege of Cardiology. J Am Coll Cardiol 2015;66: 2372-84.
  47. Bonow RO, Nishimura RA, Thompson PD, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular ab- normalities: task force 5: valvular heart disease: a scientific statement from the American Heart As- sociation and American College of Cardiology. J Am Coll Cardiol 2015;66:2385-92.
  48. Black HR, Sica D, Ferdinand K, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnor- malities: task force 6: hypertension: a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2015;66:2393-7.
  49. Braverman AC, Harris KM, Kovacs RJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular ab- normalities: task force 7: aortic diseases, including marfan syndrome: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015;66: 2398-405.
  50. Thompson PD, Myerburg RJ, Levine BD, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular ab- normalities: task force 8: coronary artery disease: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015;66:2406-11.
  51. Ackerman MJ, Zipes DP, Kovacs RJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular ab- normalities: task force 10: the cardiac channelo- pathies: a scientific statement from the American Heart Association and American College of Cardi- ology. J Am Coll Cardiol 2015;66:2424-8.
  52. Link MS, Estes NA III, Maron BJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 13: commotio cordis: a scientific statement from the American Heart Association and Amer- ican College of Cardiology. J Am Coll Cardiol 2015; 66:2439-43.
  53. Drezner JA, Courson RW, Roberts WO, et al. Inter-Association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. J Athl Train 2007;42:143-58.
  54. Link MS, Myerburg RJ, Estes NA III Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnor- malities: task force 12: emergency action plans, resuscitation, cardiopulmonary resuscitation, and automated external defibrillators: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015;66:2434-8.
  55. Drezner JA, Rao AL, Heistand J, et al. Effec- tiveness of emergency response planning for sudden cardiac arrest in United States high schools with automated external defibrillators. Circulation 2009;120:518-25.
  56. Drezner JA, Rogers KJ. Sudden cardiac arrest in intercollegiate athletes: detailed analysis and outcomes of resuscitation in nine cases. Heart Rhythm 2006;3:755-9.
  57. Vernuccio F, Grutta G, Fazio G. [Sudden car- diac death in athletes: is it always not prevent- able?]. Recenti Prog Med 2014;105:410-4.
  58. Larsen MP, Eisenberg MS, Cummins RO, et al. Predicting survival from out-of-hospital cardiac arrest: a graphic model. Ann Emerg Med 1993;22: 1652-8.
  59. Drezner JA, Toresdahl BG, Rao AL, et al. Out- comes from sudden cardiac arrest in US high schools: a 2-year prospective study from the Na- tional Registry for AED Use in Sports. Br J Sports Med 2013;47:1179-83.
  60. Bhanji F, Donoghue AJ, Wolff MS, et al. Part 14: education: 2015 American Heart Association guidelines update for cardiopulmonary resuscita- tion and emergency cardiovascular care. Circula- tion 2015;132:S561-73.
  61. Fuller CM, McNulty CM, Spring DA, et al. Prospective screening of 5,615 high school ath- letes for risk of sudden cardiac death. Med Sci Sports Exerc 1997;29:1131-8.
  62. Wilson MG, Basavarajaiah S, Whyte GP, et al. Efficacy of personal symptom and family history questionnaires when screening for inherited car- diac pathologies: the role of electrocardiography. Br J Sports Med 2008;42:207-11.
  63. Bessem B, Groot FP, Nieuwland W. The Lausanne recommendations: a Dutch experience. Br J Sports Med 2009;43:708-15.
  64. Hevia AC, Fernández MM, Palacio JMA, et al. ECG as a part of the preparticipation screening programme: an old and still present international dilemma. Br J Sports Med 2011;45:776-9.
  65. Magalski A, McCoy M, Zabel M, et al. Cardio- vascular screening with electrocardiography and echocardiography in collegiate athletes. Am J Med 2011;124:511-8.
  66. Price DE, McWilliams A, Asif IM, et al. Electrocardiography-inclusive screening strate- gies for detection of cardiovascular abnormalities in high school athletes. Heart Rhythm 2014;11: 442-9.
  67. Menafoglio A, Di Valentino M, Segatto JM, et al. Costs and yield of a 15-month pre- participation cardiovascular examination with ECG in 1070 young athletes in Switzerland: implica- tions for routine ECG screening. Br J Sports Med 2014;48:1157-61.

Cited by

Sorted by citations

Authors
Hainline, B., Drezner, J. A., Baggish, A., Harmon, K. G., Emery, M. S., Myerburg, R. J., Sanchez, E., Molossi, S., Parsons, J. T., & Thompson, P. D.
Affiliations
  • National Collegiate Athletic Association (US)
  • University of Washington (US)
  • Massachusetts General Hospital (US)
  • Indiana University School of Medicine (US)
  • University of Miami (US)
  • Baylor College of Medicine (US)
  • Hartford Hospital (US)
Corresponding author
Hainline, Brian
ORCID
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2016-06
Volume
67
Issue
25
Pages
2981-2995
ISSN
0735-1097 (ISSN-L)
DOI
10.1016/j.jacc.2016.03.527
OpenAlex
W2336342629
Cited by
92
References
4
Citations by year
2026: 2 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 10 · 2021: 11 · 2020: 13 · 2019: 7 · 2018: 11 · 2017: 7 · 2016: 15
FWCI
10.97
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Sports injuries and prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
college student-athletes, cardiovascular care, sudden cardiac death, pre-participation screening, cardiac arrest detection, cardiac arrest response, cardiovascular risk, NCAA
MeSH terms
Adult, Cardiovascular Diseases, Female, Humans, Male, Sports, Students, Universities, Death, Sudden, Cardiac, Practice Guidelines as Topic, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review